ROCHE FINANCE LTD 13D and 13G filings for Millendo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 07:02 am Unchanged |
2020-12-31 | 13G | Millendo Therapeutics, Inc. MLND |
ROCHE FINANCE LTD | 72,612 5.700% |
0 (Unchanged) |
Filing |